1. Home
  2. AUPH vs SCS Comparison

AUPH vs SCS Comparison

Compare AUPH & SCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • SCS
  • Stock Information
  • Founded
  • AUPH 1993
  • SCS 1912
  • Country
  • AUPH Canada
  • SCS United States
  • Employees
  • AUPH N/A
  • SCS N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • SCS Office Equipment/Supplies/Services
  • Sector
  • AUPH Health Care
  • SCS Consumer Discretionary
  • Exchange
  • AUPH Nasdaq
  • SCS Nasdaq
  • Market Cap
  • AUPH 1.1B
  • SCS 1.2B
  • IPO Year
  • AUPH 1999
  • SCS 1998
  • Fundamental
  • Price
  • AUPH $8.19
  • SCS $10.35
  • Analyst Decision
  • AUPH Strong Buy
  • SCS Strong Buy
  • Analyst Count
  • AUPH 2
  • SCS 2
  • Target Price
  • AUPH $11.50
  • SCS $17.00
  • AVG Volume (30 Days)
  • AUPH 1.4M
  • SCS 624.3K
  • Earning Date
  • AUPH 07-31-2025
  • SCS 06-25-2025
  • Dividend Yield
  • AUPH N/A
  • SCS 3.87%
  • EPS Growth
  • AUPH N/A
  • SCS 50.00
  • EPS
  • AUPH 0.27
  • SCS 1.02
  • Revenue
  • AUPH $247,295,000.00
  • SCS $3,166,000,000.00
  • Revenue This Year
  • AUPH $12.15
  • SCS $4.20
  • Revenue Next Year
  • AUPH $18.31
  • SCS $4.09
  • P/E Ratio
  • AUPH $30.78
  • SCS $10.15
  • Revenue Growth
  • AUPH 29.20
  • SCS 0.20
  • 52 Week Low
  • AUPH $5.15
  • SCS $9.32
  • 52 Week High
  • AUPH $10.67
  • SCS $14.74
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 54.75
  • SCS 50.67
  • Support Level
  • AUPH $7.91
  • SCS $10.24
  • Resistance Level
  • AUPH $8.07
  • SCS $10.63
  • Average True Range (ATR)
  • AUPH 0.24
  • SCS 0.23
  • MACD
  • AUPH -0.00
  • SCS 0.01
  • Stochastic Oscillator
  • AUPH 51.85
  • SCS 59.29

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About SCS Steelcase Inc.

Steelcase Inc is a furniture company based in the United States. Its brands, such as Steelcase, AMQ, Coalesse, Designtex, and others, offer a portfolio of furniture and architectural products and services designed to help customers create workplaces. It markets its products and services to businesses and organizations predominantly through a network of dealers and also sells to consumers in markets around the world through web-based and retail distribution channels. The company's reportable segments include the Americas, which generates key revenue, and the International segment.

Share on Social Networks: